Viracta Therapeutics Inc (NASDAQ:VIRX)

1.48
Delayed Data
As of May 26
 0.00 / 0.00%
Today’s Change
0.88
Today|||52-Week Range
5.75
+1.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization2.0K3.0K2.0K2.0K
 
 
 
 
 
 
Operating ExpensesGross Income-2.0K-3.0K-2.0K-2.0K
 
 
 
 
 
General Expenses6.3M5.8M5.7M6.2M
 
 
 
 
 
Research And Development3.6M3.3M3.2M3.7M
 
 
 
 
 
Total Operating Expenses6.3M5.8M5.7M6.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.3M-5.8M-5.7M-6.2M
 
 
 
 
 
Interest Expense On Debt291.0K295.0K261.0K111.0K
 
 
 
 
 
Other Expenses63.0K58.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.5M-6.0M-5.9M-6.2M
 
 
 
 
 
Net Income-6.5M-6.0M-5.9M-6.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.1M37.4M59.1M72.2M
 
 
 
 
 
Shares To Calculate EPS Diluted36.1M37.4M59.1M72.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.16-$0.10-$0.09
 
 
 
 
 
EPS Diluted-$0.18-$0.16-$0.10-$0.09